Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04408924
Title Abemaciclib (LY2835219) in Men With Heavily Treated Metastatic Castration-Resistant Prostate Cancer (CYCLONE 1)
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

prostate cancer

Therapies

Abemaciclib

Age Groups: senior | adult
Covered Countries USA | FRA | ESP


No variant requirements are available.